This content is only available within our institutional offering.
08 Feb 2019
Feedback from successful kidney disease seminar in New York
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Feedback from successful kidney disease seminar in New York
Renalytix Plc (RENX:LON) | 6.2 0 4.2% | Mkt Cap: 27.3m
- Published:
08 Feb 2019 -
Author:
Singer CM Team -
Pages:
3 -
On 6th February, RenalytixAI hosted a well-attended seminar on kidney disease in New York. The seminar brought together a formidable group of speakers and attendees representing the clinical and commercial ecosystem in chronic kidney disease (CKD), specifically in relation to current trends in diagnostics and the potential for multivariate, Artificial Intelligence (AI) enabled solutions such as RenalytixAI’s KidneyIntelX™. The seminar further strengthened our confidence in RenalytixAI’s investment case.